RSV Vaccine Proves 75% Effective Against Hospitalization in Older Adults, According to New CDC DataHalsey, GracePatient Care (Online)
"We know from the start that this vaccine has durability, which is important versus the COVID vaccine, [which] can lose efficacy after four to six months, reducing public confidence in the vaccine," Dr. Dan Barouch, director of the Center for Virology and Vaccine Research at...
The Centers for Disease Control and Prevention (CDC) updated its RSV vaccine guidance for seniors for this upcoming respiratory viral season, saying the new recommendations are meant to simplify decision-making for patients and clinicians. The new guidan
Public health experts have recommended children and adults receive the flu and COVID vaccine as well as older adults receive the RSV vaccine, but coverage is "low," according to the CDC. As of Feb 8, only 45.3% of adults were vaccinated against the flu and 23,1% were vaccinated with the...
Pfizer is developing a vaccine that protects infants from RSV, and Sanofi has asked the FDA to approve an antibody called nirsevimab that also protects children up to two years old.
Pfizer has said its maternal vaccine couldpreventup to 16,000 hospitalizations and more than 300,000 visits to the doctor due to RSV if the shot becomes available in the U.S. this fall and winter. "This fall marks the start of the annual respiratory infection season in the Northern Hem...
The Centers for Disease Control and Prevention is warning of an early surge in respiratory disease caused by multiple viruses. Asinfluenzaviruses, respiratory syncytial virus (RSV), SARS-CoV-2, and rhinovirus/enterovirus simultaneously circulate, the agency cautioned that this confluence of viral acti...
The U.S. Centers for Disease Control and Prevention have recommended the first-ever vaccine designed to protect infants from respiratory syncytial virus. The CDC said the Pfizer vaccine should be taken during weeks 32 and 36 of pregnancy.Sept 23, 2023 ...
It comes as cases of influenza and respiratory syncytial virus, or RSV, continue rising. The viruses typically spread during winter, but experts have said the surges are occurring earlier than usual. A person gets an influenza vaccine from a pharmacist during an...
Vaccine makers are still studying when seniors might need to come back for a booster dose of RSV vaccine in the coming years. They also have yet to decide on a final price, further complicating broader recommendations. GSK said their vaccine could be priced between $200 and $295 per dose,...